June 4, 2026

Day: January 21, 2022

Fermenta Biotech Limited exclusively licenses the proprietary enzymatic technology for manufacturing Molnupiravir to Aurigene Pharmaceutical Services Ltd Fermenta Biotech Limited exclusively licenses the proprietary enzymatic technology for manufacturing Molnupiravir to Aurigene Pharmaceutical Services Ltd

Fermenta Biotech Limited exclusively licenses the proprietary enzymatic technology for manufacturing Molnupiravir to Aurigene Pharmaceutical Services Ltd

Alok Agrawal January 21, 2022
New Delhi (India), January 21: Fermenta Biotech Limited (FBL) today announced that it has signed a Definitive...
Read More Read more about Fermenta Biotech Limited exclusively licenses the proprietary enzymatic technology for manufacturing Molnupiravir to Aurigene Pharmaceutical Services Ltd

You may have missed

PNN-9

VAHH Chemicals Limited’s Initial Public Offering Opens on June 4 to June 8, 2026 with Price Fixed at Rs.60 Per Share

Alok Agrawal June 3, 2026
PNN-2026-05-29T154534949

eYantra Ventures Limited Reports FY26 Annual Results

Alok Agrawal June 3, 2026
PNN-11

VMS TMT Limited Announces Q4 FY26 and FY26 Results

Alok Agrawal June 3, 2026
PNN-10

PPMS Group Joins with Prashant Janadri for Activatr – Distribution Platform for Consumer Brands

Alok Agrawal June 3, 2026